Skip to main content

Table 1 Demographic and clinical characteristics of the included patients

From: Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial

Variables

TXA study group (n = 37)

NS study group (n = 40)

P value

Female (%)

32 (82.05)

33 (80.49)

0.86†

Age (year)

77.80 ± 9.75

79.18 ± 6.50

0.54*

BMI

23.79 ± 2.18

23.27 ± 2.93

0.61*

Side (right/left)

18/19

21/19

0.74†

Preop. hemoglobin level (g/L)

109.50 ± 15.07

112.15 ± 13.31

0.51

Preop. hematocrit level (%)

32.63 ± 4.28

33.79 ± 3.83

0.31

Preop. transfusion (mL)

220.00 ± 354.80

158.00 ± 315.30

0.51

AO fracture classification

 31 A1

14

14

0.76†

 31 A2

11

15

 31 A3

12

11

ASA classification

 I

5

4

0.89^

 II

16

18

 III

16

18

 IV

2

1

Operative time (min)

81.90 ± 25.61

80.67 ± 29.44

0.88*

Hospital stay (days)

8.10 ± 1.74

9.03 ± 2.10

0.10*

  1. *Two-sided student’s t test; †chi-squared test; ^non-parametric test; TXA tranexamic acid, NS normal-saline, BMI body mass index
Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X